Khalid Islam
Founder chez GAIN THERAPEUTICS, INC.
Fortune : 6 M $ au 31/03/2024
Profil
Khalid Islam is the founder of Prev AbR LLC (founded in 2010), Ki Consulting AG (founded in 2009), Sirius Healthcare Partners GmbH (founded in 2009), Life Sciences Management GmbH (founded in 2014), and Gain Therapeutics, Inc. (founded in 2017).
He is also the founder of BioAim LLC.
Dr. Islam's current job(s) include Chairman at Fennec Pharmaceuticals, Inc. (since 2014), Chairman at Minoryx Therapeutics SL (since 2016), Chairman at GT Gain Therapeutics SA, and Advisor at Kurma Biofund FCPR.
Dr. Islam's former job(s) include Chairman & Chief Executive Officer at Gentium Srl (2009-2014), President, Chief Executive Officer & Director at Arpida AG (1999-2008), Chairman at Caerus Consulting.
AS (2010-2014), Chairman at Arpida, Inc. (2006-2009), Chairman at Pcovery ApS (2013-2015), Director at AGC Biologics SpA (2014-2016), Director at OxThera AB.
(2014-2017), Director at Rheoscience A (2007-2008), Director at Karolinska Development AB (2015-2017), Independent Director at Immunomedics, Inc. (2017-2020), Director at Processa Pharmaceuticals, Inc. (2020-2022), and Professor at the University of Milan.
Dr. Islam's education includes a doctorate degree from Imperial College London (conferred in 1983) and an undergraduate degree from Chelsea College (conferred in 1977).
Dr. Islam is also the founder of BioAim LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GAIN THERAPEUTICS, INC.
5,43% | 23/06/2023 | 880 784 ( 5,43% ) | 3 M $ | 31/03/2024 |
| 25/03/2024 | 213 825 ( 0,79% ) | 2 M $ | 31/03/2024 |
Postes actifs de Khalid Islam
| Sociétés | Poste | Début |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Chairman | 09/12/2015 |
| GAIN THERAPEUTICS, INC. | Founder | 01/01/2017 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Chairman | - |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Chairman | 01/01/2016 |
| Life Sciences Management GmbH | Chief Executive Officer | 01/02/2014 |
Kurma Biofund FCPR
 Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Corporate Officer/Principal | - |
Sirius Healthcare Partners GmbH
 Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Founder | 01/07/2009 |
Anciens postes connus de Khalid Islam
| Sociétés | Poste | Fin |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Director/Board Member | 11/07/2022 |
| IMMUNOMEDICS, INC. | Director/Board Member | 23/10/2020 |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Khalid Islam
| Imperial College London | Doctorate Degree |
| Chelsea College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| KAROLINSKA DEVELOPMENT AB | Finance |
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 22 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
| Marion Merrell Dow (Europe) AG | |
Kurma Biofund FCPR
Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Finance |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Health Technology |
Ki Consulting AG
 Ki Consulting AG Miscellaneous Commercial ServicesCommercial Services Ki Consulting AG provides management consulting services. The private company is based in Reinach, Switzerland. The Swiss company was founded by Khalid Islam. | Commercial Services |
Rheoscience A/S
 Rheoscience A/S Pharmaceuticals: MajorHealth Technology Rheoscience A/S develops and manufactures pharmaceutical products. The private company is based in Redovre, Denmark. | Health Technology |
| Arpida, Inc. | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
Adenium Biotech ApS
 Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Adenium Biotech ApS develops and commercializes novel antibiotics for the treatment of multi drug resistant bacterial infections. It focuses on treatment of nosocomial infections, in particular complicated urinary tract infections and hospital or ventilator acquired pneumonia caused by multi drug resistant Gram-negative bacteria. The company offers Arenicin, an anti-microbial peptide against gram-negative pathogens for pneumonia, urinary tract infection, and acinetobacter baumanii. Adenium Biotech was founded by Peter Nordkild on August 24, 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
Sirius Healthcare Partners GmbH
Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Finance |
| Adenium AB | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Health Technology |
Prev AbR LLC
 Prev AbR LLC BiotechnologyHealth Technology Prev AbR LLC develops biologic and beta-lactamase compounds. The private company is based in Bethesda, MD. The company was founded by Khalid Islam. | Health Technology |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Health Technology |
Elion Oncology, Inc.
 Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD. | Health Technology |
| BioAim LLC | |
Hoechst Marion Roussel Group
 Hoechst Marion Roussel Group BiotechnologyHealth Technology Part of Sanofi, Hoechst Marion Roussel Group designs molecule inhibitors. The private company is based in Frankfurt, Germany. | Health Technology |
| Life Sciences Management GmbH |
